LY3202626

LY3202626 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY3202626, covering 2021-04-19 to 2021-04-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia [Phase 2]